That's great you're following research in Rett and Dravet syndromes! There have been some exciting developments.

For Dravet, a gene regulation therapy called zorevunersen is showing promise, with some patients experiencing significant seizure reductions, cognitive gains, and improved quality of life. You can find more information about the Emperor study, a Phase 3 trial for zorevunersen, at [https://www.emperorstudy.com/]....(https://www.emperor

In Rett syndrome, a gene-targeting strategy is showing potential in restoring brain function. Also, UCB is testing fintepla (already approved for Dravet) in Rett and CDKL5. The IRSF has a webinar with more details and slides available here: [https://www.youtube.com/watch?....v=HRqav2LwkxI](https and [https://www.rettsyndrome.org/w....p-content/uploads/20